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MicroRNAs (miRNAs) are critical regulators of gene expression, 
yet much remains unknown regarding their changes resulting from 
environmental exposures as they influence cellular signaling across 
various tissues. We set out to investigate miRNA responses to for-
maldehyde, a critical air pollutant and known carcinogen that dis-
rupts miRNA expression profiles. Rats were exposed by inhalation 
to either 0 or 2 ppm formaldehyde for 7, 28, or 28 days followed 
by a 7-day recovery. Genome-wide miRNA expression profiles 
were assessed within the nasal respiratory epithelium, circulating 
white blood cells (WBC), and bone marrow (BM). miRNAs showed 
altered expression in the nose and WBC but not in the BM. Notably 
in the nose, miR-10b and members of the let-7 family, known naso-
pharyngeal carcinoma players, showed decreased expression. To 
integrate miRNA responses with transcriptional changes, genome-
wide messenger RNA profiles were assessed in the nose and WBC. 
Although formaldehyde-induced changes in miRNA and tran-
script expression were largely tissue specific, pathway analyses 
revealed an enrichment of immune system/inflammation signal-
ing in the nose and WBC. Specific to the nose was enrichment for 
apoptosis/proliferation signaling, involving let-7a, let-7c, and let-7f. 
Across all tissues and time points assessed, miRNAs were predicted 
to regulate between 7% and 35% of the transcriptional responses 
and were suggested to play a role in signaling processes including 
immune/inflammation-related pathways. These data inform our 
current hypothesis that formaldehyde-induced inflammatory sig-
nals originating in the nose may drive WBC effects.
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MicroRNAs (miRNAs) are key players in cellular responses to 
toxic agents in the environment, including carcinogens (Bailey 
and Fry, 2013). miRNAs are short (~21 nucleotides in length), 
noncoding RNAs that regulate gene expression by base pairing 
to target transcripts and causing transcript degradation and/or 
translational repression (Filipowicz et al., 2008). Estimated to 
regulate the expression of approximately 30% of all mamma-
lian protein-coding genes (Filipowicz et  al., 2008), miRNAs 
are critical mediators of gene expression. Because they play 
such pivotal roles in transcriptional regulation, miRNA expres-
sion profiles have been evaluated for associations with diseases 
such as nasopharyngeal carcinoma (Chen et al., 2009) and leu-
kemia (Garzon et al., 2008).
Toxicological studies evaluating the effects of air toxicants 
on miRNA expression have been performed. For example, 
diesel exhaust particles have been shown to disrupt miRNA 
expression profiles in human airway cells (Jardim et  al., 
2009). Only a few studies have assessed temporal changes in 
miRNA expression after exposure to environmental toxicants. 
For example, time series have been examined in response to 
lipopolysaccharide (Moschos et al., 2007). miRNA expression 
profiles have been shown to change over time after an expo-
sure ends (Moschos et al., 2007); however, differences in their 
responses resulting from various exposure durations and from 
other toxicants are understudied. Moreover, comparisons of 
exposure-induced miRNA expression changes across several 
tissues/organs of the body have not been done.
In previous research, we showed that gaseous formalde-
hyde exposure modifies miRNA expression profiles in cultured 
human airway cells (Rager et al., 2011). Following up on the in 
vitro study, we examined in vivo the nasal epithelial responses 
of nonhuman primates (Rager et al., 2013). Formaldehyde is 
of high environmental interest, as it is a common indoor and 
outdoor air pollutant (IARC, 2012; NTP, 2011). It is also a 
high-volume industrial chemical used in a large number of con-
sumer and industrial applications (IARC, 2012; NTP, 2011). 
Additionally, formaldehyde is formed endogenously through 
normal cellular metabolism (IARC, 2012; NTP, 2011). Because 
of the ubiquitous nature of both endogenous and exogenous 
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formaldehyde exposures, formaldehyde has been studied 
extensively since the 1980s. Pioneering studies demonstrated 
that formaldehyde inhalation exposure caused nasal cancer in 
rats (Kerns et al., 1983; Swenberg et al., 1980) and, to a lesser 
extent, in mice (Kerns et  al., 1983). Since then, hundreds of 
reports have been published focusing on the health effects of 
formaldehyde inhalation exposure (IARC, 2012; NTP, 2011).
Formaldehyde inhalation exposure has been associated with 
several detrimental health effects including increased risk of 
childhood asthma (McGwin et  al., 2010), upper respiratory 
tract infections (Lyapina et al., 2004), nasopharyngeal cancer 
(Hauptmann et al., 2004), and leukemia (Beane Freeman et al., 
2009). Formaldehyde is currently classified as a known human 
carcinogen by the International Agency for Research on Cancer 
(IARC, 2012) and the National Toxicology Program (NTP, 
2011). Both agencies view that there is sufficient evidence that 
formaldehyde causes cancer of the nasopharynx and leukemia, 
particularly myeloid leukemia (IARC, 2012; NTP, 2011). The 
conclusion that formaldehyde is a leukemogen has been con-
troversial, as the mechanisms by which formaldehyde could 
cause toxicity at sites distal to the respiratory tract are unknown 
(NTP, 2011).
Toxicological investigations have shown clear associations 
between formaldehyde exposure and tissue damage (Chang 
et al., 1983; Monticello et al., 1991), increases in cell prolifera-
tion (Chang et al., 1983; Monticello et al., 1991), DNA dam-
age (Lu et al., 2010, 2011; Moeller et al., 2011), inflammation 
(Andersen et al., 2008, 2010), changes in miRNA expression 
(Rager et  al., 2013), and changes in gene expression signa-
tures (Andersen et al., 2010) in direct target regions of expo-
sure. However, there is currently a lack of knowledge regarding 
inhaled formaldehyde’s ability to influence gene expression 
and miRNA expression profiles in tissues distant from the site 
of contact.
In this study, the effects of formaldehyde inhalation expo-
sure were assessed by examining miRNA endpoints across 
time and throughout multiple tissues using the rodent model. 
Specifically, genome-wide miRNA expression profiles were 
compared throughout 3 tissues: (1) the nasal epithelium, (2) 
circulating white blood cells (WBC), and (3) the bone mar-
row (BM). The miRNA responses were then integrated with 
formaldehyde-induced transcriptomic changes, where miRNA-
messenger RNA (mRNA) interactions were predicted and 
responses assessed at the systems level. This study contrib-
utes critical knowledge toward the understanding of an epi-
genetic mechanism that may underlie formaldehyde-induced 
responses, as well as a broader understanding on how miRNAs 
respond over time and across varied tissues.
MATeRiAlS ANd MeThodS
Ethics statement and animals. Animals were exposed, sedated, and 
euthanized using protocols approved by the Lovelace Respiratory Research 
Institute’s animal care and use committee. Male Fischer rats (Charles River, 
Wilmington, Massachusetts) were selected from the Lovelace Respiratory 
Research Institute colony. Animals were approximately 6 to 8 weeks of age 
and weighed between 150 and 250 g. Animals were housed, fed, and cared 
for as previously described (Lu et al., 2011). Prior to the exposures, animals 
were conditioned to nose-only exposure tubes for 6 h/day over 4 conditioning 
sessions.
Formaldehyde exposures. Rats received nose-only inhalation exposures 
of 2 ppm formaldehyde. To generate the exposure conditions, deuterated/13C 
labeled paraformaldehyde (Cambridge Isotope Laboratories, Inc.) was vapor-
ized and directed through a delivery line and into a Tedlar bag. During each 
of the exposures, 1 Tedlar bag was diluted with prefiltered air and delivered 
to the inhalation chambers at a target formaldehyde concentration of 2 ppm. 
Nose-only chamber concentrations were monitored by collecting breathing 
port samples using Waters XpoSure Aldehyde Sampler cartridges. Cartridges 
were analyzed by ultraviolet high-performance liquid chromatography.
Three exposure durations were investigated. First, the 7-day group received 
formaldehyde exposure for 7 days (6 h/day), where formaldehyde exposures 
averaged to 2.00 (± 0.08 SD). Second, the 28-day group received formalde-
hyde exposure for 28 days (6 h/day), where formaldehyde exposures averaged 
to 2.03 (± 0.06 SD). Third, a 28-day plus recovery group received formalde-
hyde exposure for 28 days (6 h/day) with a 7-day recovery period following the 
last exposure, where formaldehyde exposures averaged to 2.03 (± 0.06 SD). 
Control (unexposed) rats were placed in a nose-only exposure chamber con-
taining room air for matched durations.
Sample collection. After the last exposure or recovery period, animals 
were euthanized using an IP injection of pentobarbital-based solution (Euthasol, 
Virbac Corp., Fort Worth, Texas). Sample collection started immediately after 
the last exposure in order to parallel time of death and sample collection times 
used in our previous studies (Lu et  al., 2011; Moeller et  al., 2011). Nasal 
epithelial tissue from the nasal respiratory epithelium was collected as previ-
ously described (Lu et al., 2011) and stored in RNAlater (Qiagen, Valencia, 
California). Whole blood was collected by cardiac stick using a heparin-laced 
syringe, and WBC were isolated using Vacutainer CPT cell preparation tubes 
(Becton Dickinson, Franklin Lakes, New Jersey) and stored in TRIzol LS 
(Life Technologies, Grand Island, New York). To collect BM cells, femurs 
were flushed with saline and BM cells stored in RNAlater (Qiagen). All sam-
ples were stored at −80°C and shipped by overnight courier on dry ice to the 
University of North Carolina at Chapel Hill for further processing.
RNA isolation. Nasal epithelial tissue samples were disrupted and 
homogenized using a TissueRuptor (Qiagen) and RNA isolated using the 
miRNeasy kit (Qiagen). For the WBC, samples were homogenized in TRIzol 
(Life Technologies) and RNA isolated according to the standard TRIzol proto-
col. The BM samples were filtered through 70-μm nylon mesh filters (Fischer 
Scientific, Waltham, Massachusetts) to remove bone fragments. Filtered BM 
samples were then homogenized in TRIzol (Life Technologies) and RNA iso-
lated according to the standard TRIzol protocol. Extracted RNA was quanti-
fied with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, 
Massachusetts) and its integrity verified with a 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, California) using both the Nano and Small RNA 
kits. The quality control incorporated RNA integrity number assessment and 
electrophoretogram peak assessment of small RNA molecules.
miRNA microarray analysis. RNA samples were labeled and hybridized to 
the Agilent Rat miRNA Microarray based on miRBase v16.0. For the nose and 
BM samples, exposed and unexposed samples were assessed in biological tripli-
cate. For the WBC samples, exposed samples were assessed in biological quadru-
plicate and unexposed samples were assessed in biological triplicate. Microarray 
data have been submitted to the National Center for Biotechnology Information 
(NCBI) Gene Expression Omnibus repository (Edgar et al., 2002) and are avail-
able under accession number GSE42393 (www.ncbi.nlm.nih.gov/geo). For 
miRNA analysis, data were normalized and background noise was eliminated, 
and data were statistically assessed as previously detailed (Rager et al., 2013). In 
the case where multiple microarray chips were used, batch effect was identified 
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and removed (Partek Genomics Suite, St Louis, Missouri). Differential expres-
sion was defined as a significant difference in miRNA levels between exposed 
versus unexposed samples, where 3 statistical requirements were set: (1) fold 
change of ≥ 1.5 or ≤ −1.5 (average exposed versus average unexposed); (2) p < 
.05 (ANOVA); and (3) a false discovery rate corrected q value < .1.
Transcript (mRNA) microarray analysis. Nose and WBC RNA samples 
from the 7-day and 28-day groups were labeled and hybridized to the Affymetrix 
GeneChip Rat Gene 1.0 ST Array (Santa Clara, California). Exposed and unex-
posed samples were assessed in biological triplicate. Microarray data have been 
submitted to the NCBI Gene Expression Omnibus repository (Edgar et al., 2002) 
and are available under accession number GSE42394. To analyze the mRNA 
microarray results, data were first normalized by robust multichip average and 
background noise was eliminated by removing mRNA probes with signal intensi-
ties less than the median signal across all replicates. Differential expression was 
defined as a significant difference in mRNA levels between exposed versus unex-
posed samples, where 2 statistical requirements were set: (1) fold change of ≥ 
1.5 or ≤ −1.5 (average exposed vs average unexposed) and (2) p < .01 (ANOVA).
To assess whether changes in transcript levels reflected potential shifts in 
cell population (eg, inflammatory cell infiltrate), the formaldehyde-responsive 
transcripts were compared against a database of immune cell–specific tran-
scripts. The formaldehyde-associated transcripts identified in this study was 
compared to 1135 transcripts previously identified as specifically expressed in 
blood cell subsets (eg, B-cell lymphocytes, T-cell lymphocytes, CD8+ T-cell 
lymphocytes, and granulocytes) (Palmer et al., 2006).
Predicting miRNA transcriptional targets. Transcriptional targets of 
formaldehyde-responsive miRNAs were predicted in silico. The Ingenuity 
Knowledge Database was queried for experimentally validated miRNA-mRNA 
interactions, as well as predicted interactions based on TargetScan algorithms 
that identify potential matches between 3′-untranslated mRNA regions and 
miRNA seed sequences (http://www.targetscan.org). The resulting predicted 
miRNA-mRNA interactions were filtered for high confidence, defined as those 
with total context plus scores < −0.4. The total context plus score controls for 
factors influencing miRNA targeting, including miRNA binding site type and 
location, local adenine and uracil content, supplementary pairing, target site 
abundance, and seed-pairing stability (Garcia et al., 2011). Interactions were 
also directionally filtered to include matches between miRNAs with formalde-
hyde-induced increased expression and transcripts with formaldehyde-induced 
decreased expression, and vice versa.
Pathway enrichment analysis of transcriptional responses. The 
Comparative Toxicogenomics Database (CTD) was used to identify biologi-
cal pathways associated with formaldehyde-induced changes in transcriptional 
profiles (http://ctdbase.org). Using the Set Analyzer tool in CTD, the hyper-
geometric distribution was used to calculate the probability that the fraction 
of genes associated with a biological pathway was significantly higher than 
by chance alone (Boyle et  al., 2004). The lists of formaldehyde-associated 
transcripts were assessed using 2 biological pathway databases within CTD, 
KEGG, and REACTOME. Pathways were filtered for those with p ≤ .01.
Confirming miRNA microarray results using reverse transcriptase PCR.  
To confirm the miRNA microarray results, formaldehyde-induced changes in 
miRNA expression were validated using real-time reverse transcriptase PCR 
(RT-PCR). The same sample replicates used for the microarray analysis were 
used for RT-PCR, plated in technical triplicate. TaqMan MicroRNA Primer 
Assays for hsa-miR-31 (ID 000185)  and the U6 housekeeping miRNA (ID 
001973)  were used with the TaqMan Small RNA Assays PCR kit (Applied 
Biosystems, Carlsbad, California). The MyCyler Thermal Cycler (Bio-Rad, 
Hercules, California) was used for the reverse transcription step, and the 
Lightcycler 480 (Roche, Indianapolis, Indiana) was used for the real-time step. 
The resulting RT-PCR cycle times were normalized against the U6 housekeep-
ing miRNA, and fold changes in expression were calculated based off delta 
delta cycle time values, as previously described (Rager et al., 2013). Statistical 
significance of the difference in miRNA expression levels between the formal-
dehyde-exposed and -unexposed samples was calculated using ANOVA.
Confirming transcript microarray results using RT-PCR. To verify 
the results from the transcript microarray analysis, RT-PCR was performed 
at the gene expression level using nose samples from the 28-day rat group. 
The same sample replicates used for the microarray analysis were used for 
RT-PCR, plated in technical triplicate. QuantiTect Primer Assays were used 
with QuantiTect SYBR Green PCR kits (Qiagen) and the Stratagene Mx3005P 
QPCR System (Agilent Technologies). Specifically, chloride channel cal-
cium activated 3 (Clca3) (Cat. No. QT01570870), C-type lectin domain fam-
ily 11, member a (Clec11a) (Cat. No. QT00407043), dosage suppressor of 
mck1 homolog, meiosis-specific homologous recombination (Dmc1) (Cat. 
No. QT01627241), and secreted frizzled-related protein 4 (Sfrp4) (Cat. No. 
QT00179830) were evaluated for changes in transcript levels induced by for-
maldehyde exposure. Resulting RT-PCR cycle times were normalized against 
the β-actin housekeeping gene, and fold changes in expression were calculated 
used delta delta cycle time values, as previously described (Rager, et al., 2013). 
Statistical significance comparing the expression levels between exposed and 
unexposed samples was calculated using ANOVA.
ReSulTS
Study Design
In this study, we investigated formaldehyde-induced changes 
in miRNA expression profiles at 3 different exposure times 
and 3 different tissues. Specifically, male Fischer rats received 
nose-only inhalation exposures of 2 ppm formaldehyde (6 h/
day) for (1) 7 days, (2) 28 days, or (3) 28 days followed by a 
7-day recovery (Fig. 1). Control (unexposed) rats were placed 
in nose-only exposure tubes containing room air for the same 
duration. In order to examine the effects of formaldehyde 
across multiple tissues, samples were collected from the nasal 
epithelium, circulating mononuclear WBC, and BM cells 
immediately after the last exposure. An exposure of 2 ppm for-
maldehyde was used, as this exposure level has been shown to 
alter gene expression profiles (Andersen et al., 2010) and DNA 
adduct levels (Lu et al., 2011) in sites of direct contact in rats. 
Isotope-labeled [13CD
2
] formaldehyde was used to allow for the 
detection of exogenously produced DNA adducts in a parallel 
experiment, as in previous investigations of our research team 
(Lu et al., 2011; Moeller et al., 2011).
Formaldehyde Alters miRNA Expression in the Nose 
and WBC
To determine whether formaldehyde inhalation exposure 
modifies the expression levels of miRNAs within the rat nose, 
WBC, and BM, small RNAs from these samples were assessed 
using the Agilent Rat miRNA Microarray, release 16.0. 
Day: 0 7 14 21 28 35
7-Day Group
28-Day Group
28-Day Plus Recovery Group
2 ppm formaldehyde 0 ppm formaldehyde
FiG. 1. Design of rat formaldehyde exposure conditions over time. Control 
(unexposed) rats were treated using matched conditions.
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This array measures the expression levels of 695 rat miRNAs. 
Formaldehyde exposure was found to alter the expression lev-
els of 108 miRNAs. Specifically, 84, 59, and 0 miRNAs were 
altered in the nose in the 7-day, 28-day, and 28-day plus recov-
ery groups, respectively. Some of the formaldehyde-responsive 
miRNAs overlapped between exposure durations, as detailed in 
the next section. In the WBC, formaldehyde exposure altered 
the expression of 40 miRNAs. Specifically, 31, 8, and 3 miR-
NAs were altered in the 7-day, 28-day, and 28-day plus recovery 
groups, respectively. In the BM, no miRNAs were identified as 
significantly altered (Fig. 2A; Supplementary Table 1).
Formaldehyde-Responsive miRNAs are Tissue and  
Time Specific
Comparing the formaldehyde-responsive miRNAs across the 
different tissues revealed largely distinct miRNA responses. 
Out of a total 108 formaldehyde-responsive miRNAs within 
the nose, only 10 were also responsive within the WBC. Most 
(7/10) of these overlapping miRNAs displayed different direc-
tions of altered expression (Figs. 3A and B).
Comparing the formaldehyde-responsive miRNAs across the 
different exposure durations revealed that many miRNAs show 
similar expression changes over time in the nose but not in the 
WBC (Fig. 3C). A total of 35 miRNAs had altered expression 
levels in the nose in both the 7-day and 28-day exposure groups. 
Furthermore, 34 of these 35 miRNAs showed altered expres-
sion with similar directionality. Seven of the 34 miRNAs with 
sustained decreased expression over time, let-7a, let-7c, let-7f, 
miR-10b, miR-126, miR-21, and miR-23a, have previously 
been shown to have decreased expression in cultured lung cells 
exposed to 1 ppm formaldehyde (Rager et al., 2011). One of 
the 34 miRNAs with sustained decreased expression over time, 
miR-203, has also previously been identified as decreased in 
expression within the nasal epithelium of nonhuman primates 
FiG. 2. Distribution of (A) formaldehyde-responsive microRNAs and (B) mRNA transcripts in the rat.
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exposed to 2 and 6 ppm formaldehyde over 2 days (Rager et al., 
2013). Notably, these miRNA expression changes did not per-
sist in the rat nose after 7 days of recovery.
Formaldehyde-responsive miRNAs were less sustained 
over time within the WBC. Only 2 miRNAs had significantly 
altered expression when comparing across the 7-day, 28-day, 
and 28-day plus recovery groups (Fig. 3C). MiR-326 showed 
increased expression in both the 7-day and 28-day groups. MiR-
212 showed decreased expression in both the 7-day and 28-day 
plus recovery groups. MiR-212 also showed decreased expres-
sion (FC = −2.34, p = .008, q value = .155) in formaldehyde-
exposed WBC samples from the 28-day group, but it did not 
pass the stringent multiple test correction/q value requirement.
Formaldehyde Alters Transcript Levels in the Nose 
and WBC
To assess the influence of formaldehyde inhalation expo-
sure at the mRNA level, a transcriptomics-based analysis was 
performed using the nose and WBC samples from the 7-day 
and 28-day exposure groups. Only the nose and WBC samples 
were assessed at the transcript level, as no changes in miRNA 
expression were detected in the BM.
Transcript levels were measured using the Affymetrix 
GeneChip Rat Gene 1.0 ST Array, which assesses the expres-
sion levels of 27 342 genes. Formaldehyde exposure was found 
to cause the differential expression of 830 and 42 genes in the 
nose in the 7-day and 28-day groups, respectively (Fig.  2B; 
Supplementary Table 2). Together, these represent 864 formal-
dehyde-responsive transcripts in the nose. Notably, 209 of the 
830 formaldehyde-responsive transcripts (25%) in the nose of 
the 7-day group represent olfactory receptors. In the WBC, for-
maldehyde exposure altered the expression levels of 96 and 130 
genes in the 7-day and 28-day groups, respectively (Fig. 2B; 
Supplementary Table 2). These represent 222 total formalde-
hyde-responsive transcripts in the WBC.
Formaldehyde-Responsive Transcripts are Tissue and Time 
Specific
Comparing the formaldehyde-responsive transcripts across 
the different tissues revealed largely distinct transcriptional 
responses. Out of a total 864 formaldehyde-responsive tran-
scripts within the nose, only 18 (2%) were also responsive to 
formaldehyde exposure within the WBC (Figs. 4A and B). Only 
10 of these overlapping mRNAs displayed the same direction 
of altered expression.
Very few transcripts show similar expression patterns over 
time. Only 8 transcripts were altered in the nose in both the 
7-day and 28-day exposure groups (Fig. 4C). All 8 of these tran-
scripts notably showed altered expression with similar direc-
tionality in both exposure groups. These transcripts include one 
that showed decreased expression, namely dosage suppressor 
of mck1 homolog, meiosis-specific homologous recombina-
tion (Dmc1), and 7 transcripts that showed increased expres-
sion, namely CD34 molecule (Cd34), C-type lectin domain 
family 7, member A (Clec7a), Fc fragment of IgG, low affinity 
IIb, receptor (CD32) (Fcgr2b), lipoprotein lipase (Lpl), lym-
phocyte-specific protein 1 (Lsp1), musculoskeletal, embryonic 



























































FiG. 3. Formaldehyde-responsive miRNAs in the nose and white blood cells. A, A heat map displays formaldehyde-responsive miRNAs, shaded according 
to fold change value (FC = exposed/unexposed). B and C, Venn diagrams show how formaldehyde-responsive miRNAs overlap between tissues and exposure 
conditions. Overlapping miRNAs are enumerated in the centers of the venn diagrams, and the number of overlapping miRNAs with the same direction of altered 
expression is shown within parentheses. Abbreviation: miRNA, microRNA.
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In the WBC, only 4 transcripts were altered in both the 7-day 
and 28-day exposure groups (Fig. 4C). One of these transcripts 
was decreased in expression by formaldehyde in both exposure 
groups, namely ubiquitin protein ligase E3 component n-rec-
ognin 4 (Ubr4). The remaining transcripts were increased in 
expression in both exposure groups and included CD160 mol-
ecule (Cd160), granzyme K (Gzmk), and killer cell lectin-like 
receptor subfamily G, member 1 (Klrg1).
A Small Proportion of Formaldehyde-Responsive 
Transcripts in the Nose Are Immune Cell Specific
Formaldehyde exposure has been shown to cause inflamma-
tory cell infiltrates in the nasal epithelium of rats, specifically 
at exposure concentrations ≥ 6 ppm formaldehyde (Andersen 
et al., 2008, 2010; Pavkov et al., 1982). Although inflamma-
tory cell infiltrates resulting from 2 ppm formaldehyde are 
either unobservable or minimal (Andersen et al., 2008, 2010; 
Pavkov et  al., 1982), inflammation-related genomic signal-
ing has been identified following 2 ppm formaldehyde in the 
rat nose (Andersen et  al., 2010). Therefore, it is important 
to relate formaldehyde-induced changes in mRNA transcrip-
tional profiles to potential shifts in the inflammatory cell 
population.
To gain more information on how our results relate to 
potential inflammatory cell infiltrates, the 864 formaldehyde-
associated transcripts identified within the rat nose were com-
pared with 1135 transcripts previously identified as expressed 
specifically in immune cell subsets (eg, B-cell lymphocytes, 
T-cell lymphocytes, CD8+ T-cell lymphocytes, and granulo-
cytes) (Palmer et  al., 2006). This comparison revealed that 
only 35 of the 864 (4%) formaldehyde-responsive transcripts 
in the nose are immune cell specific (Supplementary Table 3). 
Mainly 2 immune cell subsets are represented by these 35 
formaldehyde-responsive transcripts: granulocytes and B-cell 
lymphocytes. Therefore, although the assessed nasal tissues 
likely contained a pool of epithelial cells and immune-related 
cells, the estimated genomic signaling from B cells and gran-
ulocytes represents a very small fraction of the total transcrip-
tional response.
Formaldehyde-Responsive miRNAs May Mediate a Fraction 
of the Transcriptional Effects
Interactions between formaldehyde-responsive miRNAs and 
differentially expressed transcripts were predicted based on 
previous experimental findings as well as computational pre-
dictions based on sequence matches between 3′-untranslated 
mRNA regions and miRNA seed sequences. These predictions 
revealed that, in the nose, 294 of the 830 (35%) differentially 
expressed transcripts are likely regulated by 50 miRNAs in 
the 7-day group and 9 of the 42 (21%) differentially expressed 
transcripts are likely regulated by 5 miRNAs in the 28-day 
group. In the WBC, 29 of the 96 (30%) differentially expressed 
transcripts were predicted to be regulated by 12 miRNAs in 
the 7-day group and 9 of the 130 (7%) differentially expressed 
transcripts were predicted to be regulated by 4 miRNAs in the 


























































FiG. 4. Formaldehyde-responsive transcripts in the nose and white blood cells. A, A heat map displays formaldehyde-responsive transcripts, shaded accord-
ing to fold change value (FC = exposed/unexposed). B and C, Venn diagrams show how formaldehyde-responsive transcripts overlap between tissues and exposure 
conditions. Overlapping transcripts are enumerated in the centers of the venn diagrams, and the number of overlapping transcripts with the same direction of 
altered expression is shown within parentheses.
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Pathways Are Associated With Transcriptional Responses to 
Formaldehyde
Transcripts were next assessed for relationships to biologi-
cal pathways. Analyses were carried out for the 7-day and 
28-day nose groups and 7-day and 28-day WBC groups using 
the following lists: (1) all formaldehyde-associated transcripts, 
(2) formaldehyde-associated transcripts predicted as regulated 
by formaldehyde-responsive miRNAs (ie, miRNA-dependent 
transcripts), and (3) formaldehyde-responsive transcripts not 
predicted to be regulated by miRNAs (ie, miRNA-independent 
transcripts). For inclusion, the formaldehyde-associated path-
ways had to be enriched within at least 1 list containing all 
formaldehyde-associated transcripts.
A total of 45 pathways were identified as associated with 
formaldehyde-induced transcriptomic changes (Supplementary 
Table 5). The top 10 most significant pathways associated with 
formaldehyde-induced transcriptional responses were identi-
fied to include immune system/inflammation, signal trans-
duction, mitogen-activated protein kinase (MAPK) pathway, 
neuronal system, and apoptosis/proliferation, among others 
(Fig. 5).
Microarray Results Were Confirmed Using RT-PCR
Formaldehyde-induced changes in miRNA and transcript 
expression levels identified through microarray analysis were 
validated using RT-PCR. RT-PCR was performed on miR-31, 
the miRNA with the greatest increase in expression in the 
nose of the 28-day group and also an increase in expression 
in the nose of the 7-day group. Supporting the microarray 
findings, miR-31 showed significantly increased expression 
in the formaldehyde-exposed nose samples of the 7-day and 
28-day groups through RT-PCR (Fig.  6). A  subset of genes 
differentially expressed by formaldehyde in the nose of the 
28-day group was also verified using RT-PCR. Specifically, 
Dmc1 and Clca3 were tested, as they showed the greatest 
increase and decrease in expression resulting from exposure, 
respectively. Two other genes, Clec11a and Sfrp4, were eval-
uated using RT-PCR in order to test genes that were not as 
drastically altered at the expression level but still identified as 
differentially expressed (Fig. 6).
diSCuSSioN
In this study, a multitiered approach was employed to enable 
an understanding of the genome-wide miRNA responses to 
formaldehyde and to establish how these responses relate to 
alterations in transcriptional profiles over time and in various 
tissues. Formaldehyde is a common air toxicant that we previ-
ously have shown to significantly disrupt miRNA expression 
profiles in direct target tissues in vitro (Rager et al., 2011) and 
in vivo (Rager et al., 2013). For the current study, the effects 
of formaldehyde were further evaluated in vivo across several 
tissues, where rats received nose-only inhalation exposures of 
2 ppm formaldehyde for 7 days, 28 days, or 28 days followed 
by a 7-day recovery without formaldehyde exposure and com-
pared with controls.
This investigation is the first to simultaneously examine 
exposure-induced perturbations in miRNA expression profiles 
throughout the nasal epithelium, circulating WBC, and BM. The 
nose was the site of greatest change in formaldehyde-induced 
miRNA expression profiles (n = 108 miRNAs) followed by the 
WBC (n = 40 miRNAs) after 7 and 28 days of exposure. There 
were no miRNAs that showed significantly altered expression 
in the BM. These findings suggest that cells in direct contact 
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FiG. 5. Ten pathways most associated with formaldehyde-induced transcriptional responses. Abbreviations: FA, formaldehyde; miRNA, microRNA; WBC, 
white blood cells.
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with formaldehyde exposure are more responsive at the miRNA 
level than cells distant from exposure contact sites.
Within the rat nose, formaldehyde-induced miRNA changes 
showed high stability over the exposure time points. Of the 59 
formaldehyde-responsive miRNAs in the nose of the 28-day 
group, 34 (58%) were also altered with similar directionality 
in the 7-day group. Many of these miRNAs with sustained 
expression alterations have been shown to be altered in cultured 
human lung cells exposed to formaldehyde (Rager et al., 2011). 
Specifically, let-7a, let-7c, let-7f, miR-10b, miR-126, miR-21, 
and miR-23a were all significantly decreased in expression in 
formaldehyde-exposed lung cells (Rager et  al., 2011) and in 
the nose of rats exposed to formaldehyde for 7 and 28 days. 
Of these miRNAs, let-7a, let-7c, let-7f, and miR-10b were also 
decreased in expression in nasopharyngeal carcinoma tissue in 
comparison to healthy tissue (Li et al., 2011). The downregula-
tion of the let-7 family of miRNAs (eg, let-7a, let-7c, let-7f) is 
of particular importance, as these miRNAs are implicated as 
tumor suppressors that act on apoptosis/cell proliferation path-
ways (Shenouda and Alahari, 2009). These common patterns 
of miRNA expression associated with both exposure and dis-
ease could represent etiologic relationships and warrant further 
investigation.
One of the goals of this study was to compare formalde-
hyde-altered miRNA expression to mRNA transcript levels. 
Genome-wide transcriptional profiles were assessed in the nose 
and WBC of the 7-day and 28-day group but not in the BM, as 
this was not a site of formaldehyde-altered miRNA expression. 
Within the nose, formaldehyde exposure resulted in the differ-
ential expression of 830 transcripts in rats exposed for 7 days 
and 42 transcripts in rats exposed for 28 days. Seven transcripts 
showed formaldehyde-induced expression in both exposure 
groups, namely Cd34, Clec7a, Fcgr2b, Lpl, Lsp1, Mustn1, and 
Osmr. One transcript was increased in expression by formal-
dehyde in both exposure groups, namely Dmc1. Some of these 
transcripts have previously been identified as differentially 
expressed by formaldehyde exposure. For instance, Lsp1 had 
altered expression in a previous study evaluating formalde-
hyde-induced changes in the rat nasal epithelium (Andersen 
et al., 2010).
In order to assess which of the formaldehyde-induced tran-
scriptional changes may be attributable to miRNAs, poten-
tial miRNA-mRNA interactions that occur upon exposure to 
formaldehyde were predicted. For this analysis, interactions 
between formaldehyde-responsive miRNAs and differentially 
expressed transcripts were predicted in the nose and WBC of 
the 7-day and 28-day groups. It was predicted that between 7% 
and 35% of the formaldehyde-associated transcripts were regu-
lated by formaldehyde-responsive miRNAs. These data suggest 
that the miRNAs may be operating through mechanisms other 
than mRNA degradation (Bailey and Fry, 2013; Filipowicz 
et  al., 2008) and that other transcriptional regulators, such 
as DNA methylation and histone modifications (Cedar and 
Bergman, 2009), may play a role in formaldehyde-induced 
genomic responses. Our group has shown in vitro that formal-
dehyde binds to lysine molecules in histone 4 (Lu et al., 2008). 
These findings support the potential role of histone modifica-
tion in formaldehyde-induced responses.
Because the analyzed nasal tissue contained mixed cell 
populations (ie, epithelial and immune/inflammation-related 
cells), the formaldehyde-responsive transcripts were compared 
against a list of immune cell–specific transcripts to test for 




potential cell population shifts. Only a small proportion (4%) 
of the formaldehyde-responsive transcripts in the nose is spe-
cifically expressed in immune cells, mostly comprising granu-
locytes and B-cell lymphocytes. Therefore, potential signaling 
from B cells and granulocytes represents a small fraction of the 
total transcriptional response observed in the nose.
A large number of formaldehyde-associated transcripts in the 
nose from the 7-day group (n = 209) encode olfactory recep-
tors. The olfactory receptor family initiates signal transduc-
tion pathways leading to the perception of smell (Young et al., 
2003). Because formaldehyde can have a pungent irritating 
odor at high levels (NTP, 2011), this transcriptional response is 
not unexpected. Notably, the olfactory receptor transcripts were 
not identified as differentially expressed by formaldehyde after 
28  days of exposure, suggesting a transient time-dependent 
response.
In addition to the olfactory-associated signaling, the transcrip-
tional response in the nose included immune system/inflamma-
tion and MAPK signaling-associated genes. For instance, LSP1 
plays a role in MAPK signaling, particularly in neutrophils, 
and regulates leukocyte recruitment to sites of inflammation 
(Jongstra-Bilen and Jongstra, 2006). The inflammatory-related 
signaling response observed in this study was acute, in which 
more inflammation-related miRNAs and transcripts were 
altered after 7 days in comparison to 28 days of exposure. As in 
the nose, genes associated with immune system/inflammation 
and signal transduction were altered in the WBC. For example, 
CD160 is expressed in T cells and serves as a negative regula-
tor of CD4+ T-cell activation (Cai et al., 2008). Additionally, 
GZMK and KLRG1 are expressed in natural killer cells and T 
cells and also play roles in T-cell activation (Cai et al., 2008; 
Wang et  al., 2008). Not surprising given the mRNA shifts, 
inflammation and immune-related miRNAs were also altered 
in expression by formaldehyde exposure within WBC. Altered 
here, miR-143, miR-150, and miR-342 have previously been 
shown to have altered expression in circulating leukocytes that 
are involved in acute inflammation triggered by E. coli lipopoly-
saccharide infusion in humans (Goncharova et al., 2010).
Parallel to the genomic and epigenomics endpoints assessed 
in this study, endogenous and exogenous hydroxymethyl-dG 
adducts were measured in the same tissues. Although exoge-
nous DNA adducts from the rat nose increased with increasing 
days of exposure, no exogenous DNA adducts were detected in 
the WBC following up to 28 days of exposure, measured with 
a detection capability of 1.3 adducts per 10 billion dG (Yu and 
Swenberg, in preparation). Because inhaled formaldehyde does 
not reach the circulating blood (Casanova et al., 1988; Heck 
et al., 1985; Lu et al., 2010), our research team hypothesizes 
that the inflammation-associated signaling within the nose may 
in fact drive changes in WBC signaling observed in this study. 
Our future research will investigate inflammatory response 
pathways (eg, cytokine signaling) as potential mediators of 
formaldehyde-induced genomic and epigenomic changes in the 
nose and WBC.
The relationship between formaldehyde inhalation expo-
sure and effects on the immune system has been studied 
to a limited extent. For example, formaldehyde exposure 
has been linked to both suppression and stimulation of 
the immune system, as evidenced by its association with 
increased risk of childhood asthma (McGwin et  al., 2010) 
and increased risk of upper respiratory tract infections in 
humans (Lyapina et  al., 2004). In formaldehyde-exposed 
rodents, immunomodulation has been observed through 
the assessment of antibody production in plasma (Fujimaki 
et  al., 2004). Our findings associate formaldehyde expo-
sure to transcriptional changes related to immune system/
inflammation signaling in both the nose and WBC samples 
that is not simply a result of the presence of immune-related 
cells. The data from this study suggest that miRNAs may, in 
part, regulate these immunomodulation and/or inflammatory 
responses.
To date, there are inconsistent findings regarding for-
maldehyde’s influence on gene expression within circulat-
ing blood. The expression levels of 6 transcripts in human 
peripheral whole blood samples have been shown to corre-
late with formaldehyde exposure, as evaluated using urinary 
concentrations of a formaldehyde adduct, thiazolidine-4-car-
boxylate (Li et al., 2007). In contrast, formaldehyde inhala-
tion exposure of approximately 0.7 ppm for 5 days (4 h/day) 
did not cause significant changes in gene expression patterns 
within peripheral WBC of humans (Zeller et al., 2011). None 
of these aforementioned transcripts were represented by the 
222 total transcripts identified in this study as differentially 
expressed in the WBC. The data provided here are critical 
to elucidating systemic effects of formaldehyde inhalation 
exposure.
In addition to the inflammatory-associated signaling in the 
nose, formaldehyde exposure was found to alter the expres-
sion of genes involved in apoptosis/proliferation-related sign-
aling. These genes included Dmc1 and Sfrp4, which were also 
verified using gene-specific alternative approaches. DMC1 
is essential for meiotic recombination, where targeted Dmc1 
disruption causes apoptosis (Yoshida et  al., 1998). SFRP4 
is a secreted-type WNT signaling inhibitor which plays an 
important role in the regulation of cell proliferation and cell 
death (Katoh and Katoh, 2007). The association to cell death 
and proliferation-related signaling in the nose is supportive 
of previous findings that formaldehyde inhalation exposure 
causes cell death and cytotoxicity-induced cell proliferation 
(Monticello et al., 1991) and altered genomic signaling related 
to apoptosis/proliferation (Andersen et  al., 2010) in the rat 
nasal epithelium. Cell death and proliferation responses are 
an integral part of the mode of action linking formaldehyde 
inhalation exposure to cancer of the upper respiratory tract 
(NTP, 2011; Swenberg et al., 2013). Our findings provide fur-
ther evidence of transcriptional responses related to cell death 
and proliferation in tissues of direct contact to formaldehyde 
inhalation exposure.
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CoNCluSioNS
Taken together this study advances the growing body of 
knowledge on miRNAs and their relationship to formalde-
hyde. This study presents 3 major findings: First, formalde-
hyde inhalation exposure induces tissue and time-dependent 
responses at the genomic and epigenomic level. Here, for-
maldehyde exposure significantly disrupts miRNA expres-
sion profiles within the rat nose and WBC but not within the 
BM. Although miRNAs are but 1 regulator of gene expres-
sion, this finding could inform the understanding of diseases 
associated with formaldehyde. Second, miRNAs are pre-
dicted to regulate up to 35% of formaldehyde-induced tran-
scriptional responses. Third, exposure-responsive miRNAs 
are likely regulators of critical pathways, including those 
related to immune/inflammation response and apoptosis/
proliferation. These results increase the understanding of 
mechanisms and biological pathways potentially underlying 
formaldehyde-induced health effects and also broaden the 
current knowledge on miRNA responses across time and in 
different tissues.
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